PALVELLA THERAPEUTICS, INC. (PVLA)
↓ Download CSV- Sector Manufacturing
- Incorporated NV
- Fiscal year ends Dec 31
Key ratios (FY2025)
-149.1%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $42.81M | $25.90M | $31.42M | $29.32M | $46.28M | $29.10M | $25.27M | $5.83M |
| Operating Income | -$38.60M | -$14.10M | -$11.87M | -$43.47M | -$51.83M | -$33.92M | -$27.16M | -$30.83M | -$14.59M | -$22.76M |
| Net Income | -$41.72M | -$17.43M | $18.69M | -$33.28M | -$45.74M | -$37.23M | -$25.47M | -$26.75M | -$17.65M | -$22.80M |
| EPS (Diluted) | $-3.71 | $-7.83 | $2.19 | $-0.45 | $-0.71 | $-0.68 | — | — | — | — |
| Total Assets | $59.56M | $88.23M | $7.55M | $95.49M | $153.56M | $105.01M | $141.10M | $141.34M | $103.88M | $35.06M |
| Total Liabilities | $31.58M | $25.63M | $11.43M | $67.56M | $102.81M | $73.98M | $89.75M | $101.41M | $92.35M | $9.84M |
| Shareholders' Equity | $27.98M | $62.61M | -$74.48M | -$93.78M | $50.76M | $31.03M | $51.35M | $39.94M | $11.52M | $25.23M |
| Cash & Equivalents | $57.98M | $83.60M | $7.35M | $38.63M | $117.76M | $70.44M | $62.26M | $74.87M | $37.88M | $29.36M |
| Operating Cash Flow | -$25.01M | -$10.84M | -$13.70M | -$59.93M | -$7.66M | -$45.90M | -$52.47M | -$1.07M | $49.75M | — |
| Capital Expenditures | — | — | $171.0K | $1.04M | $949.0K | $2.73M | $2.46M | $1.70M | $1.95M | $560.0K |
| Shares Outstanding | 12.38M | 11.01M | 1.77M | 74.52M | 72.22M | 56.00M | 55.21M | 54.15M | 45.02M | 43.06M |